China Shenghuo Pharmaceutical Holdings (昆明圣火药业（集团）有限公司) released its Q3 financial report and also announced that it has completed restatement of financial results for 2007 and the first two quarters of 2008. Most notable was the restatement in 2007’s net income, which dropped by a very significant $2.3 million, taking it down to $1.7 million.  In Q3, revenues climbed 73%, but net income dropped.  More details...

Stock Symbol: (AMEX: KUN)